Moneycontrol
HomeNewsBusinessMoneycontrol ResearchWhat ‘second wave’ means for investors in Indian pharma
Trending Topics
Sensex Live
Fujiyama Power Systems IPO
Excelsoft Technologies IPO
Sudeep Pharma IPO
Gold Price

What ‘second wave’ means for investors in Indian pharma

Anubhav Sahu   •

Multi-year opportunity awaits Indian vaccine manufacturers such as DRL, Gland Pharma, Aurobindo Pharma and Cadila Pharma

Volunteers distribute pamphlets during an awareness campaign on the spread of COVID-19 on a street in Mumbai. (Representative image: Reuters)

To read the full story,

Subscribe to Moneycontrol PRO
  • Ad-free Experience
  • Access Exclusive Stories
  • Weekly Investment Ideas
  • Daily Technical Calls

Are you a PRO subscriber? Sign In

What Do You Get

  • Ad free Experience

    Seamless navigation, faster responses.

  • Expert Perspective

    Explore 230+ exclusive editorials every month

  • +

    Uncover Insights from World-Renowned Experts and Journalists

  • Actionable Insights

    40+ weekly investment ideas + 3 to 4 daily technical calls

  • Virtual Events

    Exclusive Live Webinars for Expert Trading & Investment Strategies!

  • Newsletters

    Stay ahead with daily and weekly insights

View Offers

Unlock exclusive discounts

Disclosure & Disclaimer

This Research Report / Research Recommendation has been published by Moneycontrol Dot Com India Limited (hereinafter referred to as “MCD”) which is a registered Investment Advisor under the Securities and Exchange Board of India (Investment Advisers) ...Read More